<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01440244</url>
  </required_header>
  <id_info>
    <org_study_id>CE 11.092</org_study_id>
    <nct_id>NCT01440244</nct_id>
  </id_info>
  <brief_title>Cervical Video Assisted Thoracoscopic Surgery (C-VATS)</brief_title>
  <acronym>CT0030</acronym>
  <official_title>Cervical Video Assisted Thoracoscopic Surgery (C-VATS)Using a Flexible Endoscope for Thoracoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although thoracic NOTES may not be ready for human trials, a new minimally invasive technique&#xD;
      to access the pleural cavity and perform pleural, pulmonary and mediastinal procedures would&#xD;
      be possible. Cervical Video Assisted Thoracoscopic Surgery (C-VATS) is a technique that&#xD;
      borrows from traditional VATS procedures, from cervical mediastinoscopy, and from flexible&#xD;
      endoscopy. All of these procedures are very familiar to the thoracic surgeon.&#xD;
&#xD;
      The current feasibility and safety study examines C-VATS as a method of evaluating, biopsying&#xD;
      and performing pleurodesis in patients with pleural disease and or effusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: C-VATS is a feasible and safe method of entering the pleural space in order to&#xD;
      perform pleural evaluation, pleural biopsy and pleurodesis in patients with pleural disease&#xD;
      and/or pleural effusions.&#xD;
&#xD;
      Objectives: Evaluate the safety and feasibility of C-VATS in patients with pleural disease.&#xD;
&#xD;
      Design: Prospective, cohort, feasibility and safety study.&#xD;
&#xD;
      Methods: Patients referred to all thoracic surgeons in the Division of Thoracic Surgery at&#xD;
      the CHUM Notre Dame campus for the diagnosis or treatment of pleural based diseases will be&#xD;
      screened for enrolment. The investigators plan to recruit 10 patients in this initial study.&#xD;
      Eligible patients will be consented by one of the thoracic surgeons at the CHUM.&#xD;
&#xD;
      All procedures will be performing in the operating room at the CHUM Notre Dame Hospital. All&#xD;
      patients will be admitted prior to their procedure and treated on the post-operative thoracic&#xD;
      surgery ward using standard post-VATS procedural treatments. All cause, as well as procedure&#xD;
      specific morbidity will be recorded by the study investigators on the day of the procedure,&#xD;
      every day in hospital until discharge and at 1 week, 4 weeks and 12 weeks post procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>procedure-related morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>Intra-operative mortality In-hospital mortality 30-day mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain related to technique</measure>
    <time_frame>3-6months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural, hospitalization and overall cost</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Single group assignment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cervical mediastinoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cervical mediastinoscopy</intervention_name>
    <description>minimally invasive technique to perform pleural evaluation, pleural biopsy and pleurodesis</description>
    <arm_group_label>Single group assignment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible patients will be those that would be candidates for the same pleural&#xD;
             procedure (biopsy, drainage and pleurodesis) using a VATS technique&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anticoagulation including Warfarin, Heparin or Clopidogrel which cannot be stopped&#xD;
&#xD;
          -  Patients less than 18 years old&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  Patient unable to extend neck fully&#xD;
&#xD;
          -  Patients with cervical spine instability&#xD;
&#xD;
          -  Patients having had previous neck or mediastinal surgery which would preclude&#xD;
             mediastinoscopy&#xD;
&#xD;
          -  Patients having previously undergone mediastinal irradiation&#xD;
&#xD;
          -  Patients having been previously diagnosed with mediastinitis&#xD;
&#xD;
          -  Active cervical cutaneous or deep cervical infections&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moishe Liberman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche du Centre Hospitalier de l'Université de Montréal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicky Thiffault, RN, CCRP</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>23432</phone_ext>
      <email>vicky.thiffault.chum@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Moishe Liberman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pasquale Ferraro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>André Duranceau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 16, 2011</study_first_submitted>
  <study_first_submitted_qc>September 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2011</study_first_posted>
  <last_update_submitted>January 22, 2021</last_update_submitted>
  <last_update_submitted_qc>January 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mediastinoscopy</keyword>
  <keyword>pleural evaluation</keyword>
  <keyword>pleural biopsy</keyword>
  <keyword>pleurodesis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

